Hide metadata

dc.date.accessioned2018-08-24T11:47:58Z
dc.date.available2018-08-24T11:47:58Z
dc.date.created2018-06-04T15:09:28Z
dc.date.issued2018
dc.identifier.citationHjelmesæth, Jøran Åsberg, Anders Andersson, Shalini Sandbu, Rune Robertsen, Ida Johnson, Line Kristin Angeles, Philip Carlo Soriano Hertel, Jens Kristoffer Skovlund, Eva Heijer, Maria Ek, Anna-Lena Krogstad, Veronica Karlsen, Tor-Ivar Christensen, Hege Staaland Andersson, Tommy B Karlsson, Cecilia . Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL). BMJ Open. 2018, 8(5), e021878
dc.identifier.urihttp://hdl.handle.net/10852/63701
dc.description.abstractIntroduction Roux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups. Methods and analysis This open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability and pharmacokinetics (24 hours) of probe drugs and biomarkers and, second, their effects on metabolism, cardiometabolic risk factors and biomarkers. The primary outcomes will be measured as changes in: (1) all six probe drugs by absolute bioavailability area under the curve (AUCoral/AUCiv) of midazolam (CYP3A4 probe), systemic exposure (AUCoral) of digoxin and rosuvastatin and drug:metabolite ratios for omeprazole, losartan and caffeine, levels of endogenous CYP3A biomarkers and genotypic variation, changes in the expression and activity data of the drug-metabolising, drug transport and drug regulatory proteins in biopsies from various organs and (2) body composition, cardiometabolic risk factors and metabolic biomarkers. Ethics and dissemination The COCKTAIL protocol was reviewed and approved by the Regional Committee for Medical and Health Research Ethics (Ref: 2013/2379/REK sørøst A). The results will be disseminated to academic and health professional audiences and the public via presentations at conferences, publications in peer-reviewed journals and press releases and provided to all participants.en_US
dc.languageEN
dc.language.isoenen_US
dc.publisherBMJ Publishing Group
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleImpact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)en_US
dc.title.alternativeENEngelskEnglishImpact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
dc.typeJournal articleen_US
dc.creator.authorHjelmesæth, Jøran
dc.creator.authorÅsberg, Anders
dc.creator.authorAndersson, Shalini
dc.creator.authorSandbu, Rune
dc.creator.authorRobertsen, Ida
dc.creator.authorJohnson, Line Kristin
dc.creator.authorAngeles, Philip Carlo Soriano
dc.creator.authorHertel, Jens Kristoffer
dc.creator.authorSkovlund, Eva
dc.creator.authorHeijer, Maria
dc.creator.authorEk, Anna-Lena
dc.creator.authorKrogstad, Veronica
dc.creator.authorKarlsen, Tor-Ivar
dc.creator.authorChristensen, Hege Staaland
dc.creator.authorAndersson, Tommy B
dc.creator.authorKarlsson, Cecilia
cristin.unitcode185,53,11,16
cristin.unitnameAvdeling for endokrinologi, sykelig overvekt og forebyggende medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1588849
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ Open&rft.volume=8&rft.spage=e021878&rft.date=2018
dc.identifier.jtitleBMJ Open
dc.identifier.volume8
dc.identifier.issue5
dc.identifier.doihttp://dx.doi.org/10.1136/bmjopen-2018-021878
dc.identifier.urnURN:NBN:no-66249
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn2044-6055
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/63701/1/Hjelmes%25C3%25A6th%2BBMJ%2BOpen2018.pdf
dc.type.versionPublishedVersion
cristin.articleide021878


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International